265 related articles for article (PubMed ID: 26066037)
21. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).
Mohan M; Lee S; Guo C; Peri SP; Doub WH
AAPS PharmSciTech; 2017 Jul; 18(5):1585-1594. PubMed ID: 27624069
[TBL] [Abstract][Full Text] [Related]
23. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
24. Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.
Hou A; Li L; Huang Y; Singh V; Zhu C; Pan X; Quan G; Wu C
Drug Deliv Transl Res; 2018 Jun; 8(3):693-701. PubMed ID: 29600480
[TBL] [Abstract][Full Text] [Related]
25. [Stability testing of meloxicam-containing microcomposites for inhalation].
Pomázi A; Ambrus R; Szabóné Révész P
Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of highly branched cyclic dextrin as an excipient matrix in dry powder inhalers.
Kadota K; Senda A; Ito T; Tozuka Y
Eur J Pharm Sci; 2015 Nov; 79():79-86. PubMed ID: 26360838
[TBL] [Abstract][Full Text] [Related]
27. Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist.
Muralidharan P; Jones B; Allaway G; Biswal SS; Mansour HM
Sci Rep; 2020 Nov; 10(1):19771. PubMed ID: 33188247
[TBL] [Abstract][Full Text] [Related]
28. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
[TBL] [Abstract][Full Text] [Related]
29. New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy.
Rosière R; Gelbcke M; Mathieu V; Van Antwerpen P; Amighi K; Wauthoz N
Int J Oncol; 2015 Sep; 47(3):1131-42. PubMed ID: 26201404
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation.
Tang Y; Zhang H; Lu X; Jiang L; Xi X; Liu J; Zhu J
Drug Deliv; 2015; 22(5):608-18. PubMed ID: 24299495
[TBL] [Abstract][Full Text] [Related]
31. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance.
Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V
Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860
[TBL] [Abstract][Full Text] [Related]
32. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process].
Ito T
Yakugaku Zasshi; 2023; 143(4):353-358. PubMed ID: 37005236
[TBL] [Abstract][Full Text] [Related]
33. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
34. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders.
Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M
Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763
[TBL] [Abstract][Full Text] [Related]
35. Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and
Benke E; Farkas Á; Balásházy I; Szabó-Révész P; Ambrus R
Drug Dev Ind Pharm; 2019 Aug; 45(8):1369-1378. PubMed ID: 31096805
[No Abstract] [Full Text] [Related]
36. Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery.
Bahrainian S; Rouini M; Gilani K
Pharm Dev Technol; 2021 Jul; 26(6):647-660. PubMed ID: 33896355
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
[TBL] [Abstract][Full Text] [Related]
38. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
Kaewjan K; Srichana T
Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.
Farkas DR; Hindle M; Longest PW
Ann Biomed Eng; 2015 Nov; 43(11):2804-15. PubMed ID: 25986955
[TBL] [Abstract][Full Text] [Related]
40. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
Rawal T; Parmar R; Tyagi RK; Butani S
Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
